CDH9: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 23: | Line 23: | ||
[[Category:Cadherins]] | [[Category:Cadherins]] | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 05:41, 17 March 2025
CDH9 is a gene that in humans encodes the protein Cadherin 9, type 2 (T2-cadherin). It is a member of the cadherin superfamily, integral membrane proteins that mediate calcium-dependent cell-cell adhesion.
Function[edit]
The encoded protein is a type II classical cadherin from the cadherin superfamily, integral membrane proteins that mediate calcium-dependent cell-cell adhesion. Mature cadherin proteins are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. This particular cadherin is expressed specifically in the cerebral cortex and is putatively involved in synaptic adhesion, axon outgrowth and guidance.
Clinical significance[edit]
Mutations in the CDH9 gene have been associated with autism spectrum disorder and attention deficit hyperactivity disorder (ADHD).
See also[edit]
References[edit]
<references />


